Francesca Fenizia

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

Nicola Normanno, Anna Maria Rachiglio, Matilde Lambiase et al. · Annals of Oncology · 2015 · 145 citations · Full text

Capri Goim Trial, Medicine, Pathology +8

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial

Fortunato Ciardiello, Nicola Normanno, Evaristo Maiello et al. · Annals of Oncology · 2014 · 116 citations · Full text

Translational Medicine, Oncology, Gene Mutation Status +11

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma

Anna Maria Rachiglio, Riziero Esposito Abate, Alessandra Sacco et al. · Oncotarget · 2016 · 85 citations · Full text

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

Anna Maria Rachiglio, Francesca Fenizia, Maria Carmela Piccirillo et al. · Cancers · 2019 · 85 citations · Full text

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

Nicola Normanno, Anna Maria Rachiglio, Cristin Roma et al. · Journal of Cellular Biochemistry · 2012 · 69 citations